Tests ID'd for use in outcome assessment of spinal stenosis

July 12, 2012
Tests ID'd for use in outcome assessment of spinal stenosis
For patients with lumbar spinal stenosis the Oswestry Disability Index, Modified Swiss Spinal Stenosis Scale, and Patient Specific Functional Scale have been shown to possess adequate psychometric properties for use in assessment of outcome, according to a study published online July 2 in The Spine Journal.

(HealthDay) -- For patients with lumbar spinal stenosis the Oswestry Disability Index, Modified Swiss Spinal Stenosis Scale (SSS), and Patient Specific Functional Scale have been shown to possess adequate psychometric properties for use in assessment of outcome, according to a study published online July 2 in The Spine Journal.

Joshua A. Cleland, P.T., Ph.D., from Franklin Pierce University in Concord, N.H., and colleagues conducted a secondary analysis of 55 patients (mean age, 69.5 years; 43.1 percent female) with lumbar receiving outpatient participating in a . The Oswestry Disability Index, SSS, Patient Specific Functional Scale, and Numeric Pain Rating Scale (NPRS) were completed at baseline and follow-up in order to assess test-retest reliability, , and minimum levels of detectable and clinically important differences. To categorize whether patients experienced clinically meaningful change, a 15-point Global Rating of Change was conducted at follow-up.

The researchers found that the only outcome measure which showed excellent test-retest reliability was the Oswestry Disability Index, with an intraclass correlation coefficient of 0.86; all other measures ranged between fair and moderate. The Oswestry Disability Index, SSS, and Patient Specific Functional Scale showed varying levels of responsiveness but were superior to the NPRS. For the Oswestry Disability Index the minimal clinically important difference was five points.

"The results of our study indicate that the Oswestry Disability Index, SSS, and Patient Specific Functional Scale possess adequate psychometric properties to be used in the outcome assessment of patients with lumbar spinal stenosis," the authors conclude.

Explore further: Classification-based therapy no better for back pain

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Classification-based therapy no better for back pain

February 21, 2012

(HealthDay) -- Treatment of patients with lower back pain (LBP) using a classification-based physical therapy approach shows no statistically significant superiority to treatment with usual physical therapy care, according ...

Lumbar spinal stenosis lowers health-related QoL

April 7, 2012

(HealthDay) -- Patients diagnosed with lumbar spinal stenosis (LSS) have a substantial burden of illness and reduced health-related quality of life (HRQL) compared to the general population, and their HRQL is compounded by ...

Prolonged disability predictors identified for low back pain

June 28, 2012

(HealthDay) -- In patients with chronic nonspecific low back pain (LBP), impaired fasting glucose tolerance, greater pain-related disability, higher body mass index, and lower quality of life (QoL) at baseline are all associated ...

Recommended for you

The 'love hormone' may quiet tinnitus

September 23, 2016

(HealthDay)—People suffering from chronic ringing in the ears—called tinnitus—may find some relief by spraying the hormone oxytocin in their nose, a small initial study by Brazilian researchers suggests.

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.